Company Filing History:
2 out of 2,596 
2 out of 973 
Years Active: 1997
Title: Xingsheng Wan: Innovator in Monoclonal Antibody Research
Introduction
Xingsheng Wan is a notable inventor based in Upper Darby, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Xingsheng Wan's latest patents include innovative methods for monitoring exposure to the Bowman Birk inhibitor (BBI) using monoclonal antibodies. One of his patents provides a method capable of detecting BBI metabolites in a sample of body fluid or tissue. Another patent focuses on monoclonal antibodies that are differentially reactive with native BBI, further enhancing the detection capabilities for this important biomarker.
Career Highlights
Throughout his career, Xingsheng Wan has worked with prestigious institutions such as the University of Pennsylvania and the University of Rochester. His research has contributed to advancements in understanding the role of BBI in various health conditions, showcasing his commitment to improving medical diagnostics.
Collaborations
Xingsheng has collaborated with esteemed colleagues, including Ann R. Kennedy and Cameron J. Koch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of monoclonal antibody research.
Conclusion
Xingsheng Wan's contributions to the field of monoclonal antibodies and his innovative patents highlight his role as a significant inventor in biomedical research. His work continues to pave the way for advancements in medical diagnostics and treatment options.